Rafael De La Barrera

1.5k total citations
18 papers, 614 citations indexed

About

Rafael De La Barrera is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rafael De La Barrera has authored 18 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 17 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Rafael De La Barrera's work include Mosquito-borne diseases and control (18 papers), Viral Infections and Vectors (16 papers) and Malaria Research and Control (9 papers). Rafael De La Barrera is often cited by papers focused on Mosquito-borne diseases and control (18 papers), Viral Infections and Vectors (16 papers) and Malaria Research and Control (9 papers). Rafael De La Barrera collaborates with scholars based in United States, Belgium and Puerto Rico. Rafael De La Barrera's co-authors include Stephen J. Thomas, Kenneth H. Eckels, Bruce L. Innis, J. Robert Putnak, Jean‐François Toussaint, Wellington Sun, Richard G. Jarman, Leyi Lin, Luis Javier Martínez-González and Robert V. Gibbons and has published in prestigious journals such as The Journal of Infectious Diseases, Emerging infectious diseases and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Rafael De La Barrera

18 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafael De La Barrera United States	13	563	477	74	41	38	18	614
Atchareeya A-nuegoonpipat Thailand	13	573 1.0×	463 1.0×	49 0.7×	46 1.1×	35 0.9×	20	667
Monique da Rocha Queiroz Lima Brazil	15	486 0.9×	378 0.8×	45 0.6×	36 0.9×	28 0.7×	26	547
Angelia Chow Singapore	14	704 1.3×	560 1.2×	47 0.6×	60 1.5×	70 1.8×	15	786
Timothy Burgess United States	11	579 1.0×	509 1.1×	52 0.7×	20 0.5×	28 0.7×	15	652
Simone M. Costa Brazil	13	513 0.9×	428 0.9×	59 0.8×	10 0.2×	22 0.6×	21	560
D Bhattacharya India	7	286 0.5×	257 0.5×	51 0.7×	22 0.5×	18 0.5×	10	389
Daniel Ewing United States	9	271 0.5×	284 0.6×	60 0.8×	14 0.3×	16 0.4×	13	389
Szu‐Chia Hsieh Taiwan	9	355 0.6×	321 0.7×	37 0.5×	9 0.2×	55 1.4×	14	432
Chih-Yun Lai United States	9	439 0.8×	440 0.9×	77 1.0×	7 0.2×	62 1.6×	14	546
Elsa Balleydier France	10	502 0.9×	402 0.8×	47 0.6×	21 0.5×	31 0.8×	18	586

Countries citing papers authored by Rafael De La Barrera

Since Specialization

Citations

This map shows the geographic impact of Rafael De La Barrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael De La Barrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael De La Barrera more than expected).

Fields of papers citing papers by Rafael De La Barrera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael De La Barrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael De La Barrera. The network helps show where Rafael De La Barrera may publish in the future.

Co-authorship network of co-authors of Rafael De La Barrera

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael De La Barrera. A scholar is included among the top collaborators of Rafael De La Barrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael De La Barrera. Rafael De La Barrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Castilho, Márcia da Costa, Ana María Bispo de Filippis, Laís Ceschini Machado, et al.. (2024). Evidence of Zika Virus Reinfection by Genome Diversity and Antibody Response Analysis, Brazil. Emerging infectious diseases. 30(2). 310–320. 6 indexed citations

Li, Yifan, Suzanne E. Wollen-Roberts, Thembi Mdluli, et al.. (2023). Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine. EBioMedicine. 97. 104815–104815. 3 indexed citations

McCracken, Michael K., Caitlin Kuklis, Chandrika B. Kannadka, et al.. (2021). Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques. npj Vaccines. 6(1). 77–77. 9 indexed citations

Díaz, Clemente, Michael Koren, Leyi Lin, et al.. (2020). Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study. American Journal of Tropical Medicine and Hygiene. 102(5). 951–954. 12 indexed citations

Lin, Leyi, Kirsten E. Lyke, Michael Koren, et al.. (2020). Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study. American Journal of Tropical Medicine and Hygiene. 103(1). 132–141. 12 indexed citations

Lin, Leyi, Michael Koren, Kristopher Paolino, et al.. (2020). Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial. The Journal of Infectious Diseases. 223(10). 1707–1716. 19 indexed citations

Danko, Janine, Tadeusz J. Kochel, Nimfa Teneza-Mora, et al.. (2018). Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial. American Journal of Tropical Medicine and Hygiene. 98(3). 849–856. 64 indexed citations

Díaz, Clemente, Leyi Lin, Luis Javier Martínez-González, et al.. (2018). Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico. American Journal of Tropical Medicine and Hygiene. 98(5). 1435–1443. 36 indexed citations

Schmidt, Alexander C., Leyi Lin, Luis Javier Martínez-González, et al.. (2017). Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States. American Journal of Tropical Medicine and Hygiene. 96(6). 1325–1337. 53 indexed citations

10.

Watanaveeradej, Veerachai, Sriluck Simasathien, Mammen P. Mammen, et al.. (2016). Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children. American Journal of Tropical Medicine and Hygiene. 94(6). 1348–1358. 6 indexed citations

11.

Fernandez, Stefan, Stephen J. Thomas, Rafael De La Barrera, et al.. (2015). An Adjuvanted, Tetravalent Dengue Virus Purified Inactivated Vaccine Candidate Induces Long-Lasting and Protective Antibody Responses Against Dengue Challenge in Rhesus Macaques. American Journal of Tropical Medicine and Hygiene. 92(4). 698–708. 49 indexed citations

12.

Cornier, Alberto S., Stephen J. Thomas, Jorge Bertrán‐Pasarell, et al.. (2015). A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico. American Journal of Tropical Medicine and Hygiene. 93(3). 441–453. 32 indexed citations

13.

Martínez, Luis Javier, Leyi Lin, Jason M Blaylock, et al.. (2015). Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial. American Journal of Tropical Medicine and Hygiene. 93(3). 454–460. 30 indexed citations

14.

Blaylock, Jason M, et al.. (2014). Seroprevalence of Dengue Fever in US Army Special Operations Forces: Initial Results and the Way Ahead. Journal of Special Operations Medicine. 14(3). 111–111. 6 indexed citations

15.

Thomas, Stephen J., Kenneth H. Eckels, Rafael De La Barrera, et al.. (2012). A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults. American Journal of Tropical Medicine and Hygiene. 88(1). 73–88. 74 indexed citations

16.

Watanaveeradej, Veerachai, Sriluck Simasathien, Ananda Nisalak, et al.. (2011). Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants. American Journal of Tropical Medicine and Hygiene. 85(2). 341–351. 78 indexed citations

17.

Simasathien, Sriluck, Stephen J. Thomas, Veerachai Watanaveeradej, et al.. (2008). Safety and Immunogenicity of a Tetravalent Live-attenuated Dengue Vaccine in Flavivirus Naive Children. American Journal of Tropical Medicine and Hygiene. 78(3). 426–433. 71 indexed citations

18.

Putnak, J. Robert, Rafael De La Barrera, Timothy Burgess, et al.. (2008). Comparative Evaluation of Three Assays for Measurement of Dengue Virus Neutralizing Antibodies. American Journal of Tropical Medicine and Hygiene. 79(1). 115–122. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact